Characterization of the ETEC Virulence Regulator Rns

ETEC 毒力调节剂 Rns 的表征

基本信息

项目摘要

DESCRIPTION (provided by the applicant): Worldwide enterotoxigenic E. coli (ETEC) cause an estimated 210 million episodes of diarrheal disease and 380,000 deaths annually. The impact of this pathogen is greatest among infants and children less than 5 years of age. Adherence of the pathogen to the intestinal mucosa of the host is essential for the establishment of an infection. Attachment is usually achieved by pili which bind specific host receptors. The expression of CS1 and CS2 pili is positively regulated at the level of transcription by Rns a member of the AraC/XylS family. There are two Rns binding sites immediately upstream of the CS1 pilin promoter, within the region expected for a typical prokaryotic activator. Rns also positively autoregulates its own expression, however it does so through a highly unusual arrangement of DNA binding sites. Rns requires two DNA binding sites for the activation of its own promoter Prns. One of these is site 1 which is centered 224.5 bp upstream of the transcription start site (TSS), considerably further upstream than expected. Even more unusual is the location of site 3, which is centered 83.5 bp downstream of the TSS. Only a few prokaryotic activators are known to have binding sites downstream of the -10 hexamer. However we have shown that the virulence regulators VirF from Shigella flexneri, CfaR from ETEC, and AggR from enteroaggregative E. coli are also capable of activating Prns and like Rns, each requires the downstream binding site to do so. To date Rns is the only virulence regulator within this group for which an in vitro system has been developed. Thus our in vitro system, coupled with complimentary genetic analysis, affords us an outstanding opportunity to use Rns as a model system for a group of related regulators. These regulators are essential for the virulence of several pathogenic species of bacteria that collectively kill over 2 million people, predominantly children and infants, every year. A detailed understanding of these homologous regulators may eventually lead to new applications for disease treatment and prevention, such as attenuation of bacterial virulence by targeting the function of conserved virulence regulators. Our proposed studies will also provide new and fundamentally important information about transcription and its regulation because of the unique features of Rns autoregulation. These include activation from a downstream binding site and the potential repression of Prns by nonproductive RNAP open (RPo) complexes. Studies in this proposal will determine the molecular mechanism of Rns positive autoregulation and the biological significance of Rns-independent, nonproductive RPo complexes near Prns.
性状(由申请方提供):全球产肠球菌E.大肠杆菌(ETEC)每年估计造成2.1亿例腹泻病和38万例死亡。这种病原体对婴儿和5岁以下儿童的影响最大。病原体粘附于宿主的肠粘膜对于感染的建立是必不可少的。附着通常通过结合特异性宿主受体的皮利来实现。CS 1和CS2皮利的表达在转录水平上受到AraC/XylS家族成员Rns的正调控。在CS 1菌毛蛋白启动子的上游有两个Rns结合位点,在典型的原核激活剂预期的区域内。Rns也积极地自动调节其自身的表达,但它是通过一种非常不寻常的DNA结合位点排列来实现的。Rns需要两个DNA结合位点来激活其自身的启动子Prns。其中之一是位于转录起始位点(TSS)上游224.5 bp处的位点1,比预期的要远得多。更不寻常的是位点3的位置,其位于TSS下游83.5 bp处。已知只有少数原核激活剂在-10六聚体下游具有结合位点。然而,我们已经表明来自福氏志贺菌的毒力调节因子VirF、来自ETEC的CfaR和来自肠聚集性E.大肠杆菌也能够激活Prns和类似的Rns,每一个都需要下游结合位点来这样做。到目前为止,Rns是该组中唯一的毒力调节剂,已开发出体外系统。因此,我们的体外系统,加上免费的遗传分析,为我们提供了一个很好的机会,使用RNS作为一组相关监管机构的模型系统。这些调节剂对几种致病性细菌的毒力至关重要,这些细菌每年总共杀死200多万人,主要是儿童和婴儿。对这些同源调节子的详细了解可能最终导致疾病治疗和预防的新应用,例如通过靶向保守毒力调节子的功能来减弱细菌毒力。由于Rns自身调节的独特功能,我们提出的研究也将提供关于转录及其调节的新的和根本上重要的信息。这些包括从下游结合位点的激活和非生产性RNAP开放(RPo)复合物对Prns的潜在抑制。在这个建议中的研究将确定Rns积极的自动调节的分子机制和Rns独立的,非生产性RPo复合物附近的Prns的生物学意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE Patrick MUNSON其他文献

GEORGE Patrick MUNSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE Patrick MUNSON', 18)}}的其他基金

Identification of Protein-Protein Interactions and Processing Events That Traffic and Activate the Bactericidal Pore-Forming Protein Perforin-2
鉴定蛋白质-蛋白质相互作用以及运输和激活杀菌成孔蛋白 Perforin-2 的加工事件
  • 批准号:
    10195288
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Identification of Protein-Protein Interactions and Processing Events That Traffic and Activate the Bactericidal Pore-Forming Protein Perforin-2
鉴定蛋白质-蛋白质相互作用以及运输和激活杀菌成孔蛋白 Perforin-2 的加工事件
  • 批准号:
    10356159
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Analyzing the expression and activation of Perforin-2 -a bactericidal pore-forming protein- with single domain antibodies
使用单域抗体分析 Perforin-2(一种杀菌性成孔蛋白)的表达和激活
  • 批准号:
    10320041
  • 财政年份:
    2020
  • 资助金额:
    $ 32.09万
  • 项目类别:
Killing of intracellular bacteria by Perforin-2
Perforin-2 杀死细胞内细菌
  • 批准号:
    8968229
  • 财政年份:
    2014
  • 资助金额:
    $ 32.09万
  • 项目类别:
Killing of intracellular bacteria by Perforin-2
Perforin-2 杀死细胞内细菌
  • 批准号:
    9193612
  • 财政年份:
    2014
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterization of the ETEC Virulence Regulator Rns
ETEC 毒力调节剂 Rns 的表征
  • 批准号:
    7011169
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterization of the ETEC Virulence Regulator Rns
ETEC 毒力调节剂 Rns 的表征
  • 批准号:
    7344773
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterization of the ETEC Virulence Regulator Rns
ETEC 毒力调节剂 Rns 的表征
  • 批准号:
    7578244
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterization of the ETEC Virulence Regulator Rns
ETEC 毒力调节剂 Rns 的表征
  • 批准号:
    6924167
  • 财政年份:
    2005
  • 资助金额:
    $ 32.09万
  • 项目类别:
FUNCTIONAL ANALYSIS OF RNS, A VIRULENCE REGULATOR
毒力调节剂 RNS 的功能分析
  • 批准号:
    6169411
  • 财政年份:
    2000
  • 资助金额:
    $ 32.09万
  • 项目类别:

相似海外基金

PREDICTING CARIES RISK IN UNDERSERVED CHILDREN, FROM TODDLERS TO THE SCHOOL-AGE YEARS, IN PRIMARY HEALTHCARE SETTINGS
预测初级医疗保健机构中从幼儿到学龄儿童的龋齿风险
  • 批准号:
    10361268
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    9751077
  • 财政年份:
    2011
  • 资助金额:
    $ 32.09万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    9976990
  • 财政年份:
    2011
  • 资助金额:
    $ 32.09万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    10457019
  • 财政年份:
    2011
  • 资助金额:
    $ 32.09万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    10213006
  • 财政年份:
    2011
  • 资助金额:
    $ 32.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了